1. Home
  2. SPOT vs MRNA Comparison

SPOT vs MRNA Comparison

Compare SPOT & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spotify Technology S.A.

SPOT

Spotify Technology S.A.

N/A

Current Price

$581.29

Market Cap

108.1B

ML Signal

N/A

Logo Moderna Inc.

MRNA

Moderna Inc.

N/A

Current Price

$196.25

Market Cap

91.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SPOT
MRNA
Founded
2006
2010
Country
Sweden
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.1B
91.2B
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
SPOT
MRNA
Price
$581.29
$196.25
Analyst Decision
Buy
Hold
Analyst Count
41
23
Target Price
★ $635.60
$164.53
AVG Volume (30 Days)
1.7M
★ 11.3M
Earning Date
10-22-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 21.77
EPS
★ N/A
N/A
Revenue
N/A
★ $19,263,000,000.00
Revenue This Year
$13.51
$24.09
Revenue Next Year
$14.92
$11.33
P/E Ratio
$38.70
★ N/A
Revenue Growth
N/A
★ 4.29
52 Week Low
$405.00
$23.55
52 Week High
$635.00
$280.80

Technical Indicators

Market Signals
Indicator
SPOT
MRNA
Relative Strength Index (RSI) 50.18 41.43
Support Level $457.84 $181.02
Resistance Level $635.00 $254.48
Average True Range (ATR) 19.42 18.33
MACD -4.81 -7.45
Stochastic Oscillator 8.18 5.92

Price Performance

Historical Comparison
SPOT
MRNA

About SPOT Spotify Technology S.A.

Spotify is the leading global music streaming service, with over 750 million monthly active users and nearly 300 million paying subscribers, with the latter constituting the firm's premium segment. Most of the firm's revenue and nearly all its gross profit come from subscribers, who pay a monthly fee to access a music library that includes most of the most popular songs ever recorded, including all from the major record labels. The firm also offers access to audiobooks and integrates podcasts within its standard music app. Podcast content is not exclusive and is typically free to access on other platforms. Ad-supported users can access a similar music catalog, but cannot customize a similar on-demand experience.

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Share on Social Networks: